Delivery Order SPE2DR25D2014-SPE2DR26FA7S7

<p>The Defense Logistics Agency issued a $1,426.13 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Hydralazine 20 mg/mL vial supply.</p> <p>Place of performance is Conshohocken, PA 19428. The order carries an ultimate completion date of February 18, 2026, and is priced on a firm fixed-price basis. No set-aside was used in the award.</p>

The Defense Logistics Agency issued a $3,557.89 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Hydralazine 20 mg/ml vials, with an ultimate completion date of March 3, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is firm fixed...

The Defense Logistics Agency awarded a $4,773.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/ml vials of hydralazine. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for hydralazine supports the Agency's mission to provide critical medical supplies to military treatment facilities worldwide. Amerisourcebergen...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Hydromorphone 10 mg/mL vials with a ceiling value of $3,508.53 under a firm fixed-price structure.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 24, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Hydromorphone 1 mg/mL vial with a ceiling value of $1,380.00 and an ultimate completion date of February 12, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside applied.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Hydralazine 20 mg/mL vials under a firm fixed-price arrangement. The contract, with a ceiling value of $1,604.30 and a completion date of September 8, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $8,043.44 for Hydromorphone 10 mg/mL vials.</p> <p>Place of performance is Conshohocken, PA. The order is due for completion on February 11, 2026. Pricing is firm fixed price. No set-aside was applied to this order.</p>

<p>The Defense Logistics Agency issued a $1,987.20 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Hydromorphone 1 mg/mL vials.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 12, 2026. No set-aside was used.</p>

The Defense Logistics Agency Troop Support Medical awarded a $225,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/mL vials of hydralazine. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this delivery order will provide the DLA with approximately $225,000 worth of...

The Defense Logistics Agency awarded a $2,802.01 delivery order to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/ml vials. This competitive, non-set-aside contract has a firm fixed price structure with an ultimate completion date of November 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical...